Riskpilot← Back to searchSign inGet full accessMEDEQ GROUP AS
ASActiveOrg 916688474Råholtvegen 74C, 2070 RåholtRetail sale of medical and orthopaedic goods · NACE 4774Est. 20162 employees
Revenue 2022
NOK 11,4M
+15% vs 2021
EBITDA margin
-5.1%
-4971% vs 2021
Equity ratio
25.8%
Financial strength
Net profit 2022
NOK -536K
-1861% vs 2021
| Revenue | NOK 11,4M | +15% |
| EBITDA | NOK -584K | -4971% |
| Net profit | NOK -536K | -1861% |
| Total assets | NOK 4,9M | +30% |
| Equity | NOK 1,3M | +61% |
| Employees | 2 | — |
Legal name
MEDEQ GROUP AS
Org number
916688474
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
8. februar 2016
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Drive salg og tilvirkning av medisinske hjelpemidler for eldre og funksjonshemmede, samt alt som faller inn under dette.
Address
Råholtvegen 74C, 2070 Råholt
Phone
+4748408888
Email
post@medeqgroup.no
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 4 665 | 6 701 | 9 017 | 9 891 | 11 382 |
| Staff expenses | −559 | −708 | −1 052 | −1 506 | −1 785 |
| EBITDA | −567 | 151 | 1 629 | 12 | −584 |
| Depreciation & amort. | −6 | −6 | −6 | −8 | −54 |
| EBIT | −572 | 146 | 1 623 | 4 | −638 |
| Net financials | 45 | −2 | −35 | 22 | −16 |
| Profit before tax | −527 | 144 | 1 588 | 26 | −654 |
| Tax | −78 | −159 | 358 | −5 | −118 |
| Net profit | −449 | 303 | 1 230 | 30 | −536 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 2 025 | 2 371 | 3 661 | 3 766 | 4 881 |
| Equity | −592 | −480 | 750 | 780 | 1 258 |
| Long-term debt | 722 | 722 | 0 | 0 | 315 |
| Short-term debt | 1 894 | 2 128 | 2 911 | 2 985 | 3 309 |
| Total debt | 2 616 | 2 850 | 2 911 | 2 985 | 3 623 |
EBITDA margin
-5.1%
This company
15.8%
Market median
-132% vs market
20182022
Equity ratio
25.8%
This company
38.2%
Market median
-32% vs market
20182022
Return on equity
-42.6%
This company
18.4%
Market median
-332% vs market
20182022
Net profit margin
-4.7%
This company
8.1%
Market median
-158% vs market
20182022
Asset turnover
2.33×
This company
1.12×
Market median
+108% vs market
20182022
Debt / equity
2.88×
This company
0.62×
Market median
-365% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GR Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2023 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Rytterager Holding As
MEDEQ GROUP AS Board members of MEDEQ GROUP AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gitte Rytterager | Chief Executive Officer | 0 companies |
| Henning Rytterager | Chairman | 0 companies |
| Svein Rytterager | Chairman | 0 companies |